Teyi Pharmaceutical Group Co.,Ltd (002728.SZ)
CNY 8.88
(-0.22%)
CNY 8.88
(-0.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 198.91 Million | 371.65 Million | 256.81 Million | 168.98 Million | 221.64 Million | 187.96 Million |
| Net Income | 253.17 Million | 178.2 Million | 126.91 Million | 43.81 Million | 171.71 Million | 155.54 Million |
| Depreciation & Amortization | 60.17 Million | 52.52 Million | 51.3 Million | 51.03 Million | 45.61 Million | 42.12 Million |
| Deferred income taxes | 1.11 Million | 1.8 Million | -1.3 Million | -3.33 Million | -1.3 Million | -7.55 Million |
| Stock-based compensation | 1.5 Million | 2.48 Million | 230.8 Thousand | - | - | - |
| Change in working capital | -145.26 Million | 112.27 Million | 31.22 Million | 21.72 Million | -36.16 Million | -42.23 Million |
| Other non-cash items | 294.51 Million | 24.36 Million | 48.43 Million | 52.41 Million | 40.48 Million | 32.53 Million |
| Investing Cash Flow | -85.89 Million | -103.33 Million | 147.25 Million | 125.81 Million | -575.2 Million | 63.74 Million |
| Investments in PPE | -86.04 Million | -90.26 Million | -109.57 Million | -89.41 Million | -130.79 Million | -152.44 Million |
| Acquisitions | 155.14 Thousand | 93.75 Thousand | 521.43 Thousand | 25.66 Thousand | 102.89 Thousand | - |
| Investment purchases | -73 Million | -13.5 Million | -6.25 Million | -533 Million | -853.98 Million | -320 Million |
| Sales/Maturities of investments | 73 Million | 339.46 Thousand | 12.55 Million | 15.2 Million | 5.48 Million | 11.41 Million |
| Other Investing Activities | 515.94 Thousand | 0.55 | 249.99 Million | 732.99 Million | 403.98 Million | 204.77 Million |
| Financing Cash Flow | -105.44 Million | -101.17 Million | -356.73 Million | -93.29 Million | 16.52 Million | -7.67 Million |
| Debt repayment | -339.25 Million | -517 Million | -836.12 Million | -722.68 Million | -482.57 Million | -314.14 Million |
| Dividends payments | -149.01 Million | -147.61 Million | -138.38 Million | -163.96 Million | -149.85 Million | -118.45 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 382.83 Million | 563.44 Million | 617.76 Million | 793.35 Million | 648.94 Million | 424.92 Million |
| Accounts receivables | -8.01 Million | -34.02 Million | 13.97 Million | 10.05 Million | 15.71 Million | -52.47 Million |
| Accounts payables | -72.83 Million | 157.24 Million | 13.16 Million | 16.51 Million | -34.18 Million | 9.3 Million |
| Inventory | -63.59 Million | -12.75 Million | 5.38 Million | -1.51 Million | -16.38 Million | 8.49 Million |
| Other working capital | -814.87 Thousand | 1.8 Million | -1.3 Million | -3.33 Million | -1.3 Million | -50.72 Million |
| Cash at beginning of period | 739.66 Million | 372.07 Million | 324.74 Million | 123.23 Million | 460.27 Million | 216.23 Million |
| Cash at end of period | 647.24 Million | 539.23 Million | 372.07 Million | 324.74 Million | 123.23 Million | 460.27 Million |
| Capital Expenditure | -86.04 Million | -90.26 Million | -109.57 Million | -89.41 Million | -130.79 Million | -152.44 Million |
| Effect of forex changes on cash | -99.99 Million | -0.64 | 0.59 | 0.76 | 0.87 | 1.36 |
| Net cash flow / Change in cash | -92.41 Million | 167.15 Million | 47.33 Million | 201.5 Million | -337.03 Million | 244.04 Million |
| Free Cash Flow | 112.87 Million | 281.39 Million | 147.23 Million | 79.56 Million | 90.85 Million | 35.52 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.32 Million | -6.46 Million | 9.15 Million | 253.17 Million | 64.69 Million | 36.35 Million |
| Depreciation & Amortization | - | 15.98 Million | 15.98 Million | 60.17 Million | 16.05 Million | 16.05 Million |
| Deferred income taxes | - | - | - | 1.11 Million | 70.91 Million | - |
| Stock-based compensation | - | - | - | 1.5 Million | 1.5 Million | - |
| Change in working capital | - | -3.77 Million | - | -145.26 Million | -72.42 Million | - |
| Other non-cash items | 1.92 Million | 20.2 Million | -48.53 Million | 294.51 Million | 45.69 Million | -38.29 Million |
| Investing Cash Flow | -121.13 Million | -122.84 Million | -46.81 Million | -85.89 Million | -11.54 Million | -28.27 Million |
| Investments in PPE | -13.98 Million | -38.83 Million | -23.82 Million | -86.04 Million | -24.54 Million | -15.54 Million |
| Acquisitions | 1840.00 | 600.00 | 500.00 | 155.14 Thousand | - | 1150.00 |
| Investment purchases | 357.01 Million | -357.01 Million | - | -73 Million | -73 Million | - |
| Sales/Maturities of investments | 850.91 Thousand | 249.98 Million | 21.46 Thousand | 73 Million | 73 Million | - |
| Other Investing Activities | -107.99 Million | 43.01 Million | -23 Million | 515.94 Thousand | 13 Million | -12.72 Million |
| Financing Cash Flow | 200.37 Million | -60.25 Million | -78.47 Million | -105.44 Million | -72.46 Million | 168.5 Million |
| Debt repayment | -189.65 Million | -154.34 Million | -10 Million | -339.25 Million | -75.57 Million | -149.88 Million |
| Dividends payments | -182.36 Million | -180.98 Million | -1.38 Million | -149.01 Million | -3.48 Million | -895.1 Thousand |
| Common Stock Repurchased | 3.98 Million | -3.98 Million | - | - | -366.29 Thousand | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 16.12 Million | -210.61 Million | -68.47 Million | 382.83 Million | 6.59 Million | 319.28 Million |
| Accounts receivables | - | 35.71 Million | - | -8.01 Million | -8.01 Million | - |
| Accounts payables | - | - | - | -72.83 Million | - | - |
| Inventory | - | -39.48 Million | - | -63.59 Million | -63.59 Million | - |
| Other working capital | - | - | - | -814.87 Thousand | -814.87 Thousand | - |
| Cash at beginning of period | 196.81 Million | 562.58 Million | 647.24 Million | 739.66 Million | 604.8 Million | 350.3 Million |
| Cash at end of period | 280.45 Million | 407.24 Million | 562.58 Million | 647.24 Million | 647.24 Million | 504.37 Million |
| Capital Expenditure | -13.98 Million | -38.83 Million | -23.82 Million | -86.04 Million | -24.54 Million | -15.54 Million |
| Effect of forex changes on cash | - | - | 79.99 Million | -99.99 Million | 1535.00 | -270.08 Thousand |
| Net cash flow / Change in cash | 83.63 Million | -155.33 Million | -84.66 Million | -92.41 Million | 42.43 Million | 154.07 Million |
| Free Cash Flow | -8.73 Million | -41.07 Million | -63.2 Million | 112.87 Million | 101.89 Million | -1.43 Million |
ADEN
GNTA
TTZ
2157
TPS
TIG